Related Experiment Videos
Increases in depression after cholesterol-lowering drug treatment
K W Davidson1, S Reddy, P McGrath
1Dalhousie University in Halifax, Nova Scotia.
Behavioral Medicine (Washington, D.C.)
|January 1, 1996
Summary
Cholesterol-lowering interventions may increase depressive symptoms in some patients. Further research is needed to explore the link between low cholesterol, depression, and brain chemistry.
Area of Science:
- Cardiology
- Psychiatry
- Neuroscience
Background:
- Cholesterol-lowering interventions are common for cardiovascular health.
- Potential side effects of these interventions require thorough investigation.
Purpose of the Study:
- To explore the potential association between cholesterol-lowering treatments and increased depressive symptoms.
- To assess changes in depression scores in patients undergoing lipid-lowering therapy.
Main Methods:
- A cohort of 6 men referred to a lipid clinic participated.
- The Center for Epidemiological Studies-Depression (CES-D) scale was administered pre- and post-intervention.
- Cholesterol levels were monitored over a 6-week period.
Main Results:
- All patients achieved reduced cholesterol levels after the 6-week intervention.
- Four out of six patients experienced an increase in depression scores.
- Two of these four patients met criteria for mild clinical depression.
Conclusions:
- A potential link exists between cholesterol reduction and increased depressive symptoms.
- Further investigation into the relationship between low cholesterol, depression, and serotonergic activity is warranted.